跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 13,889 条关于
“LOX”
全部
13,889
临床试验
13,143
药物
296
机构
43
资讯
407
8天前
Yuhan Wins U.S. Patent for Preclinical LOX-Inhibitor Candidate Targeting Multi-Organ Fibrosis
9个月前
Cadrenal Therapeutics Acquires First-in-Class 12-LOX Inhibitor VLX-1005 for Heparin-Induced Thrombocytopenia Treatment
去年
iVeena Submits IND Application for Novel Non-Atropine Eye Drop to Treat Pediatric Myopia
7个月前
iVeena Delivery Systems Initiates First-in-Human Phase 1 Trial of IVMED-85 for Myopia Prevention
4个月前
Syntara Raises $10 Million to Advance Amsulostat Phase 2b Trial in Myelofibrosis
去年
iVeena Secures $2 Million NIH Grant to Advance First-in-Class Pediatric Myopia Eye Drop
2个月前
iVeena Delivery Systems Announces Successful Phase 1 Results for IVMED-85, a First-in-Class Lysyl Oxidase Activator for Pediatric Myopia
11个月前
Advances in Cancer Immunotherapy Reveal Complex Interplay Between Tumor Microenvironment and Neoantigen Targeting
去年
LOXO-435 Shows Promise as Selective FGFR3 Inhibitor in Metastatic Urothelial Cancer Trial
去年
Eli Lilly Advances LOXO-435 in Phase 1 FORAGER-1 Study for FGFR3-Altered Advanced Cancers
第 1 页,共 41 页
上一页
下一页